GLUCOSE, ANHYDROUS
Injury
Baskent UniversitySmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the Injury cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TESTOSTERONE UNDECYLATE Craig Hospital | Phase 4 | BB |
Tranexamic Acid Daniel Nishijima, MD, MAS | Phase 3 | BB |
MIDAZOLAM Baskent University | Phase 4 | BB |
PROPRANOLOL Hamad Medical Corporation | Phase 4 | BB |
Epoetin Alfa Australian and New Zealand Intensive Care Research Centre | Phase 3 | B |
View all 29 →
Same molecule, other indications
GLUCOSE, ANHYDROUS is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →